Farnesyltransferase inhibitor tipifarnib is well tolerated, induces stabilization of disease, and inhibits farnesylation and oncogenic/tumor survival pathways in patients with advanced multiple myeloma
| Autor: | Alsina, Melissa, Fonseca, Rafael, Wilson, Edward F., Belle, A. Nelida, Gerbino, Elvira, Price-Troska, Tammy, Overton, Rose M., Ahmann, Gregory, Bruzek, Laura M., Adjei, Alex A., Kaufmann, Scott H., Wright, John J., Sullivan, Daniel, Djulbegovic, Benjamin, Cantor, Alan B., Greipp, Philip R., Dalton, William S., Sebti, Saïd M. * |
|---|---|
| Zdroj: | In Blood 1 May 2004 103(9):3271-3277 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|